A clinical study to evaluate the efficacy of Kalajaji taila orally in Artava kshaya, Oligohypomenorrhea for a period of 3 consecutive menstrual cycles

An open label double arm randomized controlled clinical study on the efficacy of Kalajaji taila orally in Artava Kshaya, Oligohypomenorrhea - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069778

Enrollment

Registered

2024-07-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. PATIENTS WILLING TO BE PART OF TREATMENT OF ARTAVAKSHAYA, OLIGOHYPOMENORRHEA. 2. PATIENTS FULFILLING THE CARDINAL SYMPTOMS OF ARTAVAKSHAYA, OLIGOHYPOMENORRHEA. 3. WOMEN OF AGE GROUP 18- 40 YEARS.

Exclusion criteria

Exclusion criteria: 1. MARKED ANEMIA (HB LESSER THAN 7G). 2. SUBJECTS ON ORAL CONTRACEPTIVE PILLS, INTRA UTERINE CONTRACEPTIVE DEVICES. 3. SUBJECTS SUFFERING FROM ANY SYSTEMIC ILLNESS SUCH AS HYPERTENSION AND DIABETES MELLITUS. 4. LACTATING WOMEN.

Design outcomes

Primary

Measure	Time frame
Significant reduction in signs and symptoms of Artava Kshaya, oligohypomenorrhea based on grading.Timepoint: Baseline, 3 months	—

Secondary

Measure	Time frame
Improved quality of life & prevent recurrence in patients diagnosed with Artava Kshaya, oligohypomenorrhea.Timepoint: Baseline, 3 months	—

Countries

India

Contacts

Public ContactDr Pratheeksha M

Sri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Anchepalya, Bengaluru

dranusham@sdmayurbangalore.in8105777424

Outcome results